BOSTON, March 30, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not...
Jayson Punwani will moderate a discussion on Impact Investing at BIO International Convention 2013 in Chicago.
News | 04. 22. 2013
Jayson Punwani will moderate a discussion on Impact Investing at BIO International Convention 2013 in Chicago.
